603998 方盛製藥
按盤價 
12.250 -0.100 (-0.810%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 14.945 | 13.119 | 22.106 | 5.967 | 5.600 |
| 總資產報酬率 ROA (%) | 7.166 | 6.224 | 10.160 | 2.831 | 3.011 |
| 投入資產回報率 ROIC (%) | 9.536 | 8.286 | 14.412 | 4.057 | 3.831 | 邊際利潤分析 |
| 銷售毛利率 (%) | 72.856 | 68.098 | 67.283 | 64.054 | 63.738 |
| 營業利潤率 (%) | 18.473 | 12.063 | 18.529 | 6.362 | 5.660 |
| 息稅前利潤/營業總收入 (%) | 19.043 | 13.150 | 19.336 | 6.921 | 6.465 |
| 淨利潤/營業總收入 (%) | 16.870 | 11.030 | 15.441 | 4.462 | 4.205 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 78.986 | 75.810 | 44.270 | 119.633 | 128.593 |
| 價值變動淨收益/利潤總額(%) | 16.814 | -1.870 | 50.887 | -10.422 | -27.158 |
| 營業外收支淨額/利潤總額(%) | 0.386 | 3.390 | -1.673 | -9.806 | -4.934 | 償債能力分析 |
| 流動比率 (X) | 0.749 | 0.738 | 1.192 | 0.690 | 0.908 |
| 速動比率 (X) | 0.474 | 0.475 | 0.888 | 0.486 | 0.668 |
| 資產負債率 (%) | 47.922 | 48.434 | 48.401 | 51.797 | 43.564 |
| 帶息債務/全部投入資本 (%) | 31.290 | 33.877 | 30.423 | 27.052 | -- |
| 股東權益/帶息債務 (%) | 208.813 | 183.662 | 210.940 | 245.510 | 270.844 |
| 股東權益/負債合計 (%) | 101.286 | 97.710 | 98.279 | 85.381 | 117.880 |
| 利息保障倍數 (X) | 38.228 | 19.796 | 17.386 | 6.143 | 6.034 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 49.367 | 42.791 | 42.267 | 48.957 | 0.000 |
| 存貨周轉天數 (天) | 262.839 | 218.853 | 171.968 | 149.076 | 0.000 |
| 備註： | 即時報價更新時間為 05/11/2024 10:41 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
